Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 256 AL 270

Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains

Hejazi L, Wong JW, Cheng D, Proschogo N, Ebrahimi D, Garner B, Don AS.

Biochem J. 2011 Aug 15;438(1):165-75. doi: 10.1042/BJ20110566.

A comparison of voxel and surface based cortical thickness estimation methods

Clarkson MJ, Cardoso MJ, Ridgway GR, Modat M, Leung KK, Rohrer JD, Fox NC, Ourselin S.

Neuroimage. 2011 Aug 1;57(3):856-65. doi: 10.1016/j.neuroimage.2011.05.053. Epub 2011 May 26.

Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease

Voronkov M, Braithwaite SP, Stock JB.

Future Med Chem. 2011 May;3(7):821-33. doi: 10.4155/fmc.11.47.

A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease

Articus K, Baier M, Tracik F, Kühn F, Preuss UW, Kurz A.

Int J Clin Pract. 2011 Jul;65(7):790-6. doi: 10.1111/j.1742-1241.2011.02713.x. Epub 2011 Jun 6.

Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease

Weiner MW, Sadowsky C, Saxton J, Hofbauer RK, Graham SM, Yu SY, Li S, Hsu HA, Suhy J, Fridman M, Perhach JL.

Alzheimers Dement. 2011 Jul;7(4):425-35. doi: 10.1016/j.jalz.2010.09.003. Epub 2011 Jun 8.

Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease

Brown PJ, Devanand DP, Liu X, Caccappolo E; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Jun;68(6):617-26. doi: 10.1001/archgenpsychiatry.2011.57.

Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's disease

Akinleye I, Roberts JS, Royal CD, Linnenbringer E, Obisesan TO, Fasaye GA, Green RC.

J Genet Couns. 2011 Dec;20(6):650-9. doi: 10.1007/s10897-011-9377-6. Epub 2011 Jun 9.

Anesthetic modulation of neuroinflammation in Alzheimer's disease

Tang JX, Eckenhoff MF, Eckenhoff RG.

Curr Opin Anaesthesiol. 2011 Aug;24(4):389-94. doi: 10.1097/ACO.0b013e32834871c5.

Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis

Supnet C, Bezprozvanny I.

Cell Calcium. 2011 Sep;50(3):303-9. doi: 10.1016/j.ceca.2011.05.013. Epub 2011 Jun 12.

Normalization of gene expression using SYBR green qPCR: a case for paraoxonase 1 and 2 in Alzheimer's disease brains

Leduc V, Legault V, Dea D, Poirier J.

J Neurosci Methods. 2011 Aug 30;200(1):14-9. doi: 10.1016/j.jneumeth.2011.05.026. Epub 2011 Jun 13.

Carotenoids and Alzheimer's disease: an insight into therapeutic role of retinoids in animal models

Obulesu M, Dowlathabad MR, Bramhachari PV.

Neurochem Int. 2011 Oct;59(5):535-41. doi: 10.1016/j.neuint.2011.04.004. Epub 2011 Jun 7.

Variant Alzheimer disease with spastic paraparesis: a rare presenilin-1 mutation

Pettersen JA, Patry DG, St George-Hyslop PH, Curry B.

Can J Neurol Sci. 2011 Jul;38(4):659-61. doi: 10.1017/s0317167100012233.

Rvx 208

Drugs R D. 2011;11(2):207-13. doi: 10.2165/11595140-000000000-00000.

Tau as a therapeutic target for Alzheimer's disease

Boutajangout A, Sigurdsson EM, Krishnamurthy PK.

Curr Alzheimer Res. 2011 Sep;8(6):666-77. doi: 10.2174/156720511796717195.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias